Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-03-13
DOI
10.1038/s41467-017-02242-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment
- (2017) Ying-Chao Duan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Stepwise assembly of functional C-terminal REST/NRSF transcriptional repressor complexes as a drug target
- (2017) Ken Inui et al. PROTEIN SCIENCE
- A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC
- (2015) Helai P. Mohammad et al. CANCER CELL
- The drug–target residence time model: a 10-year retrospective
- (2015) Robert A. Copeland NATURE REVIEWS DRUG DISCOVERY
- Structural and functional characterization of a cell cycle associated HDAC1/2 complex reveals the structural basis for complex assembly and nucleosome targeting
- (2015) Toshimasa Itoh et al. NUCLEIC ACIDS RESEARCH
- The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
- (2015) Daniel Zingg et al. Nature Communications
- A Selective Phenelzine Analogue Inhibitor of Histone Demethylase LSD1
- (2014) Polina Prusevich et al. ACS Chemical Biology
- Episensitization: Therapeutic Tumor Resensitization by Epigenetic Agents: A Review and Reassessment
- (2014) Bryan Oronsky et al. Anti-Cancer Agents in Medicinal Chemistry
- Chromatin Repressive Complexes in Stem Cells, Development, and Cancer
- (2014) Anne Laugesen et al. Cell Stem Cell
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- Long Non-Coding RNA BANCR Promotes Proliferation in Malignant Melanoma by Regulating MAPK Pathway Activation
- (2014) Ruiya Li et al. PLoS One
- Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains
- (2013) Mathew P. Martin et al. ACS Chemical Biology
- Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells
- (2013) Shauna N. Vasilatos et al. CARCINOGENESIS
- Selective Inhibition of p300 HAT Blocks Cell Cycle Progression, Induces Cellular Senescence, and Inhibits the DNA Damage Response in Melanoma Cells
- (2013) Gai Yan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
- (2013) Cory M. Johannessen et al. NATURE
- Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner
- (2012) Lihua Jin et al. BIOCHEMICAL JOURNAL
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Structure of HDAC3 bound to co-repressor and inositol tetraphosphate
- (2012) Peter J. Watson et al. NATURE
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- Epigenetic protein families: a new frontier for drug discovery
- (2012) Cheryl H. Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Impact of enzyme concentration and residence time on apparent activity recovery in jump dilution analysis
- (2011) Robert A. Copeland et al. ANALYTICAL BIOCHEMISTRY
- Antitumor Activity of YM155, a Selective Small-Molecule Survivin Suppressant, Alone and in Combination with Docetaxel in Human Malignant Melanoma Models
- (2011) Kentaro Yamanaka et al. CLINICAL CANCER RESEARCH
- Directed Evolution of Sortase A Mutants with Altered Substrate Selectivity Profiles
- (2011) Kirill Piotukh et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Structurally Designedtrans-2-Phenylcyclopropylamine Derivatives Potently Inhibit Histone Demethylase LSD1/KDM1,,§
- (2010) Shinya Mimasu et al. BIOCHEMISTRY
- Comparative Analysis of Small Molecules and Histone Substrate Analogues as LSD1 Lysine Demethylase Inhibitors
- (2010) Jeffrey C. Culhane et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Biochemical, Structural, and Biological Evaluation of Tranylcypromine Derivatives as Inhibitors of Histone Demethylases LSD1 and LSD2
- (2010) Claudia Binda et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases
- (2010) P.-H. Huang et al. MOLECULAR PHARMACOLOGY
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
- (2009) J. Bostrom et al. SCIENCE
- Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases
- (2008) Beth Apsel et al. Nature Chemical Biology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More